Filing Details
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:PMVP
PMV Pharmaceuticals, Inc. (PMVP) Files Quarterly Report for Q0
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) filed its quarterly report (Form 10-Q) with the SEC on August 14, 2026.
- The company's stock trades at $1.26 with a market capitalization of $66.8 million.
- The 10-Q filing contains unaudited financial statements and management commentary on recent performance, including emerging trends and updated risk factors.
Market Context
PMV Pharmaceuticals, Inc.'s stock currently trades at $1.26 with a market capitalization of $66.8M.
The 10-Q provides PMV Pharmaceuticals, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for PMV Pharmaceuticals, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PMVP Stock Page
Frequently Asked Questions
Where can I read PMVP's SEC filings?
Browse all filings on our PMVP SEC filings page.
What types of SEC filings does PMV Pharmaceuticals, Inc. file?
Public companies like PMV Pharmaceuticals, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.